全球液体添加剂成长机会
市场调查报告书
商品编码
1351238

全球液体添加剂成长机会

Global Liquid Dosage Excipients Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 82 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

对以患者为中心的肠外製剂的需求推动了成长潜力

液体给药辅料全球研究分析了2022年至2030年北美、欧洲、亚太、拉丁美洲和中东非洲等关键区域市场的口服液和注射用辅料市场的成长情况,评估机会。口服溶液辅料市场提供各个细分市场的定性和定量分析,例如甜味剂、pH 调节剂/缓衝剂、润湿剂/增溶剂等(螯合剂、防腐剂、调味剂等)。在口服液体製剂领域,用于治疗儿童和老年人各种疾病的新药认证数量不断增加可能会在预测期内推动需求。全球肠胃外辅料市场的研究领域包括增溶剂、缓衝剂、防腐剂及其他(补剂、螯合剂、抗氧化剂、填充剂等)。治疗癌症、罕见疾病和心血管疾病等疾病的生技药品的需求将成为预测期内肠外辅料市场的主要成长要素。

目录

战略问题

  • 为什么成长如此困难?
  • The Strategic Imperative 8(TM)
  • 液体添加剂产业三大策略问题的影响
  • 成长机会推动Growth Pipeline Engine(TM)

成长机会分析

  • 分析范围
  • 分割
  • 市场定义 - 药用辅料
  • 市场定义
  • 市场定义 - 其他关键定义
  • 主要竞争
  • 全球医药市场概况
  • 全球医药市场趋势
  • 促进因素
  • 成长促进因素分析
  • 成长抑制因素
  • 生长抑制分析
  • 价值链
  • 成长指标
  • 预测假设
  • 收益预测
  • 收益预测分析
  • 按类型分類的收益预测
  • 地区收益预测
  • 按类型和地区分類的收益预测分析
  • 竞争环境
  • 竞争生态系统
  • 竞争基准化分析
  • 市场活动 - 新产品发布、併购、合作伙伴关係、业务扩展(2020-2023)
  • 价格趋势和预测分析

成长机会分析-口服液体添加剂

  • 成长指标
  • 收益和预测
  • 按类型分類的收益预测
  • 地区收益预测
  • 预测分析
  • 按类型进行预测分析
  • 区域预测分析

成长机会分析 - 肠外添加剂

  • 成长指标
  • 收益预测
  • 按类型分類的收益预测
  • 地区收益预测
  • 预测分析
  • 按类型进行预测分析
  • 区域预测分析

成长机会宇宙

  • 成长机会 1 - 新辅料开发需要独立核准途径
  • 基于生长机会 2-mRNA 的疗法
  • 成长机会 3 - 有效儿童用的需求
  • 成长机会 4 - 特用注射剂/仿製药的差异化能力

下一步

  • 下一步
  • 为什么现在要霜冻?
  • 附件清单
  • 免责声明
简介目录
Product Code: PEF5-88

Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential

The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Liquid Dosage Excipient Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Market Definitions-Pharmaceutical Excipients
  • Market Definitions
  • Market Definitions-Other Key Definitions
  • Key Competitors
  • Global Pharmaceutical Market Overview
  • Global Pharmaceutical Market Trends
  • Growth Drivers
  • Growth Drivers Analysis
  • Growth Restraints
  • Growth Restraint Analysis
  • Value Chain
  • Growth Metrics
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis by Type and Region
  • Competitive Environment
  • Competitive Ecosystem
  • Competitive Benchmarking
  • Market Activities-New Product Launches, M&As, Partnerships, and Expansions, 2020-2023
  • Pricing Trends and Forecast Analysis

Growth Opportunity Analysis-Oral Liquid Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis
  • Forecast Analysis by Type
  • Forecast Analysis by Region

Growth Opportunity Analysis-Parenteral Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis
  • Forecast Analysis by Type
  • Forecast Analysis by Region

Growth Opportunity Universe

  • Growth Opportunity 1-Need for an Independent Approval Pathway for Novel Excipient Development
  • Growth Opportunity 2-mRNA-based Therapeutics
  • Growth Opportunity 3-Need for Effective Pediatric Drug Delivery Solutions
  • Growth Opportunity 4-Differentiated Capabilities for Injectable Specialty Generics

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer